This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Envarsus XR 4 mg tablets, a prescription medication. The contract has a ceiling value of $1,711.95 and a period of performance through July 9, 2025. This is a firm-fixed-price delivery order contract without a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Envarsus XR 4 mg tablets, a specialty medication, with a ceiling value of $3,230.68 and a period of performance through October 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 1 mg tablets, a pharmaceutical product. The contract has a ceiling value of $1,288.86 and a performance period extending through May 28, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 4 mg tablets, a specialized medication. The total ceiling value of the contract is $1,711.95, with a performance period ending on April 17, 2025. This contract is not designated as a set-aside procurement. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 1 mg tablets, a medication used for transplant recipients. The delivery order has a ceiling value of $1,288.86 and a completion date of June 11, 2025. It is a firm-fixed-price contract, without any set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,711.95, is for the delivery of Envarsus XR 4 mg tablets over a performance period ending on May 29, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of Envarsus XR 4 mg tablets, a specialty pharmaceutical product, with a ceiling value of $4,845.99 and a period of performance through May 1, 2024. The contract is structured as a firm fixed price delivery order and does not have a set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 4 mg tablets, a medication used in organ transplant patients. The contract has a ceiling value of $3,423.90 and is a firm fixed price contract. The period of performance extends through May 27, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Envarsus XR 0.75 mg tablets. The contract has a ceiling value of $2,128.84 and a period of performance ending on September 10, 2024. It is a Firm Fixed Price contract with no set-aside designation. The contract is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Envarsus XR 4 mg tablets, a medication used for transplant patients. The contract has a firm fixed price of $5,135.85 and a completion date of May 1, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside for any specific business category. The award is part of a larger Indefinite...